Header cover image

U.S. Personal Products Industry Analysis

UpdatedMay 29, 2022
DataAggregated Company Financials
Companies111
  • 7D7.8%
  • 3M-14.7%
  • 1Y-24.5%
  • YTD-32.3%

In the last week, the Personal Products industry is up 7.8%, with Estée Lauder Companies up 6.2%. In the past year, the industry is down 25%. Looking forward, earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sun, 29 May 2022US$124.8bUS$36.7bUS$2.9b16.5x
Tue, 26 Apr 2022US$131.0bUS$36.1bUS$2.8b15.7x
Thu, 24 Mar 2022US$134.3bUS$36.1bUS$2.8b17.7x
Sat, 19 Feb 2022US$144.9bUS$35.4bUS$3.1b18.1x
Mon, 17 Jan 2022US$157.3bUS$34.5bUS$2.7b17.7x
Wed, 15 Dec 2021US$173.2bUS$34.4bUS$2.7b17.5x
Fri, 12 Nov 2021US$169.8bUS$34.2bUS$3.2b16.6x
Sun, 10 Oct 2021US$159.1bUS$33.1bUS$2.8b17.3x
Tue, 07 Sep 2021US$154.4bUS$33.1bUS$2.1b15.8x
Thu, 05 Aug 2021US$151.1bUS$33.0bUS$2.3b16.9x
Sun, 09 May 2021US$144.6bUS$29.7bUS$369.4m18.4x
Wed, 10 Feb 2021US$119.0bUS$28.6b-US$469,120,769.2318.3x
Tue, 03 Nov 2020US$93.2bUS$27.5b-US$269,066,519.0016x
Fri, 07 Aug 2020US$85.0bUS$27.9b-US$286,999,267.0016x
Thu, 30 Apr 2020US$76.9bUS$28.3b-US$2,493,275,628.0015.4x
Sun, 02 Feb 2020US$88.2bUS$30.0b-US$1,438,175,234.0014.3x
Wed, 06 Nov 2019US$89.2bUS$31.3b-US$2,333,747,380.0021.4x
Sat, 10 Aug 2019US$86.8bUS$30.7b-US$2,468,232,426.0019.5x
Median PE Ratio

20x


Total Market Cap: US$80.4bTotal Earnings: US$770.3mTotal Revenue: US$33.1bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Median PE3Y Average 17.3x202020212022
Current Industry PE
  • Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 17.3x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have grown 55% per year over the last three years.
  • Revenues for these companies have grown 3.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.S. Personal Products compare with similar industries?

US Market6.18%
Consumer Staples6.32%
Personal Products7.77%
Personal Products7.77%
Industry PEThere is insufficient data on the sub-industries of this industry.
Forecasted GrowthThere is insufficient data on the sub-industries of this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL Estée Lauder CompaniesUS$251.866.2%
+US$5.2b		-17.8%PS26.8x
OLPX Olaplex HoldingsUS$17.3619.9%
+US$1.9b		n/aPS47.5x
COTY CotyUS$7.0812.9%
+US$679.7m		-20.5%PS49.3x
SKIN Beauty HealthUS$14.6422.2%
+US$400.7m		2.8%PS7.7x
ELF e.l.f. BeautyUS$25.9822.3%
+US$250.5m		-7.2%PS62.4x
Simply Wall St™
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate Program
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

OLPX

US$17.36

Olaplex Holdings

7D

19.9%

1Y

n/a

EL

US$251.86

Estée Lauder Companies

7D

6.2%

1Y

-17.8%

ELF

US$25.98

e.l.f. Beauty

7D

22.3%

1Y

-7.2%

VERU

US$12.83

Veru

7D

-4.1%

1Y

45.3%
May 27

Veru: On Right Track For FDA EUA Submission

An Emergency Use Authorization submission of sabizabulin for high-risk hospitalized Covid-19 patients is expected Q2 of 2022. With EUA and then possibly NDA occurring for sabizabulin, Veru would be in a good position to develop advance purchase orders with several Government agencies around the world. Sabizabulin is also being explored for prostate cancer and breast cancer in the pipeline; Enobosarm is another drug being developed for breast cancer. Veru had $112 million in cash as of March 31, 2022; enough to fund its operations for at least the next 12 months.

EPC

US$36.76

Edgewell Personal Care

7D

8.1%

1Y

-19.0%
May 27
Edgewell Personal Care (NYSE:EPC) Takes On Some Risk With Its Use Of Debt

Edgewell Personal Care (NYSE:EPC) Takes On Some Risk With Its Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

FLGC

US$0.99

Flora Growth

7D

-5.7%

1Y

-75.4%

BRBR

US$26.12

BellRing Brands

7D

4.6%

1Y

-8.9%

SMFL

US$0.49

Smart for Life

7D

-5.8%

1Y

n/a

MED

US$173.19

Medifast

7D

6.4%

1Y

-47.9%
May 17

Medifast: Growth And Value At A Reasonable Price

Positive Q1 results that confirm our thesis. Unique business proposition, self-financed with a virtuous circle. Better 2022 outlook with double-digit growth and a solid track record.

COTY

US$7.08

Coty

7D

12.9%

1Y

-20.5%

SKIN

US$14.64

Beauty Health

7D

22.2%

1Y

2.8%
May 13

Beauty Health: Skincare Today And Alpha Tomorrow

Beauty Health's fiscal 2022 first quarter results came in strong with revenue up more than 58%. The stock reacted by falling double digits as investors panicked over the compression of adjusted EBITDA. Forward revenue guidance for fiscal 2022 will provide legs to the bulls.

SISI

US$1.74

Shineco

7D

-4.4%

1Y

-78.1%